月湖免疫治疗 MLTX
$11.53 +$0.73 (+6.76%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $11.60 +0.61%
开盘$11.14
昨收$10.80
当日区间$11.01 – $11.55
成交量1.03M
市值$981.28M
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$0.00
营业利润-$61.66M-1.6% YoY
净利润-$61.81M-10.3% YoY
摊薄每股收益-$0.84+3.4% YoY
自由现金流-$55.56M-1.9% YoY
经营现金流-$55.56M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
净资产收益率-67.4%
资产收益率-51.0%
投入资本回报率-53.7%
流动比率12.56
负债/资产比率25.4%
现金及投资$537.03M
总负债$100.29M
净现金（净负债）$436.74M
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 营业总收入 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 营业费用 | $61.66M | $70.02M | $244.83M | $65.22M | $71.43M |
| 销售及管理费用 | $11.44M | $15.51M | $41.97M | $9.21M | $10.80M |
| -管理费用 | $11.44M | $15.51M | $41.97M | $9.21M | $10.80M |
| 研发费用 | $50.22M | $54.52M | $202.86M | $56.01M | $60.64M |
| 营业利润 | -$61.66M | -$70.02M | -$244.83M | -$65.22M | -$71.43M |
| 非经营性利息净收入（支出） | -$2.63M | -$2.27M | -$7.25M | -$1.99M | -$3.20M |
| 非经营性利息支出 | $2.63M | $2.27M | $7.25M | $1.99M | $3.20M |
| 其他收入（支出） | $2.58M | $3.21M | $22.37M | $4.44M | $4.05M |
| 证券出售收益 | -$294,000.00 | – | – | – | – |
| 其他非经营性收入（支出） | $2.87M | $3.21M | $22.37M | $4.44M | $4.05M |
| 税前利润 | -$61.72M | -$69.09M | -$229.71M | -$62.77M | -$70.58M |
| 税费 | $90,000.00 | $622,000.00 | $611,000.00 | $248,000.00 | $115,000.00 |
| 净利润 | -$61.81M | -$69.71M | -$230.32M | -$63.02M | -$70.69M |
| 持续经营利润 | -$61.81M | -$69.71M | -$230.32M | -$63.02M | -$70.69M |
| 少数股东权益 | $0.00 | $0.00 | -$3.00M | -$591,000.00 | -$965,000.00 |
| 归属母公司净利润 | -$61.81M | -$69.71M | -$227.32M | -$62.43M | -$69.73M |
| 归属普通股股东净利润 | -$61.81M | -$69.71M | -$227.32M | -$62.43M | -$69.73M |
| 基本每股收益 | -$0.84 | -$0.98 | -$3.53 | -$0.92 | -$1.10 |
| 摊薄每股收益 | -$0.84 | -$0.98 | -$3.53 | -$0.92 | -$1.10 |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $573.95M | $400.37M | $424.43M | $424.43M | $414.34M |
| 流动资产合计 | $570.04M | $396.64M | $421.69M | $421.69M | $411.22M |
| 现金及现金等价物与短期投资 | $537.03M | $357.92M | $393.97M | $393.97M | $380.48M |
| -现金及现金等价物 | $477.91M | $298.49M | $334.52M | $334.52M | $350.74M |
| -短期投资 | $59.13M | $59.43M | $59.45M | $59.45M | $29.74M |
| 应收款 | $6.56M | $5.76M | $4.87M | $4.87M | $4.02M |
| -其他应收款 | $6.56M | $5.76M | $4.87M | $4.87M | $4.02M |
| 预付资产 | $26.45M | $32.96M | $22.86M | $22.86M | $26.71M |
| 非流动资产合计 | $3.91M | $3.73M | $2.74M | $2.74M | $3.12M |
| 固定资产净值 | $2.57M | $2.39M | $2.14M | $2.14M | $2.53M |
| -固定资产原值 | $2.57M | $2.39M | $2.14M | $2.14M | $2.53M |
| 其他非流动资产 | $1.34M | $1.34M | $596,000.00 | $596,000.00 | $587,000.00 |
| 负债合计 | $145.75M | $146.35M | $119.95M | $119.95M | $123.14M |
| 流动负债合计 | $45.39M | $46.11M | $45.48M | $45.48M | $48.37M |
| 应付款 | $19.38M | $24.78M | $30.65M | $30.65M | $26.30M |
| -应付账款 | $17.04M | $23.38M | $28.43M | $28.43M | $23.82M |
| -应付税款合计 | $2.35M | $1.40M | $1.09M | $1.09M | $1.01M |
| 一年内应计费用 | $22.15M | $18.22M | $11.27M | $11.27M | $16.37M |
| 短期债务及融资租赁负债 | $1.25M | $920,000.00 | $1.23M | $1.23M | $1.50M |
| -一年内到期融资租赁负债 | $1.25M | $920,000.00 | $1.23M | $1.23M | $1.50M |
| 非流动负债合计 | $100.36M | $100.24M | $74.47M | $74.47M | $74.78M |
| 长期债务及融资租赁负债 | $100.29M | $99.88M | $74.47M | $74.47M | $74.23M |
| -长期债务 | $99.51M | $99.02M | $74.10M | $74.10M | $73.74M |
| -长期融资租赁负债 | $772,000.00 | $865,000.00 | $374,000.00 | $374,000.00 | $486,000.00 |
| 员工福利 | $74,000.00 | $353,000.00 | $0.00 | $0.00 | $549,000.00 |
| 股东权益合计 | $428.20M | $254.02M | $304.48M | $304.48M | $291.19M |
| 股东权益 | $428.20M | $254.02M | $304.48M | $304.48M | $288.91M |
| 股本 | $8,000.00 | $7,000.00 | $7,000.00 | $7,000.00 | $6,000.00 |
| -普通股 | $8,000.00 | $7,000.00 | $7,000.00 | $7,000.00 | $6,000.00 |
| 资本公积 | $1.02B | $786.31M | $766.78M | $766.78M | $689.11M |
| 留存收益 | -$594.42M | -$532.62M | -$462.91M | -$462.91M | -$400.49M |
| 不影响留存收益的损益 | $630,000.00 | $322,000.00 | $604,000.00 | $604,000.00 | $278,000.00 |
| -其他应付款 | – | – | $1.13M | $1.13M | $1.46M |
| 少数股东权益 | – | – | $0.00 | $0.00 | $2.29M |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$55.56M | -$66.29M | -$196.01M | -$58.79M | -$44.54M |
| 持续经营经营活动现金流净额 | -$55.56M | -$66.29M | -$196.01M | -$58.79M | -$44.54M |
| 持续经营净利润 | -$61.81M | -$69.71M | -$230.32M | -$63.02M | -$70.69M |
| 持续经营损益 | $9,000.00 | $11,000.00 | -$58,000.00 | -$31,000.00 | -$18,000.00 |
| 折旧、折耗与摊销 | $896,000.00 | $845,000.00 | $2.62M | $751,000.00 | $745,000.00 |
| 其他非现金项目 | $19,000.00 | $422,000.00 | -$1.02M | -$92,000.00 | $283,000.00 |
| 营运资金变动 | $2.78M | -$11.21M | $19.88M | $6,000.00 | $21.43M |
| -应收款变动 | -$798,000.00 | -$894,000.00 | -$2.03M | -$847,000.00 | -$612,000.00 |
| -预付资产变动 | $6.51M | -$10.10M | $561,000.00 | $3.86M | $274,000.00 |
| -应付账款及应计费用变动 | -$2.55M | $950,000.00 | $23.15M | -$2.63M | $21.06M |
| -其他流动资产变动 | $9,000.00 | -$779,000.00 | -$587,000.00 | $0.00 | $1.11M |
| -其他流动负债变动 | -$395,000.00 | -$389,000.00 | -$1.22M | -$377,000.00 | -$401,000.00 |
| 投资活动现金流净额 | $322,000.00 | $98,000.00 | $202.99M | -$29.91M | $88.40M |
| 持续经营投资活动现金流净额 | $322,000.00 | $98,000.00 | $202.99M | -$29.91M | $88.40M |
| 固定资产购置及出售净额 | $0.00 | $0.00 | -$35,000.00 | $0.00 | $0.00 |
| 投资购置及出售净额 | $322,000.00 | $98,000.00 | $203.03M | -$29.91M | $88.40M |
| 筹资活动现金流 | $234.62M | $30.64M | $146.00M | $72.40M | $480,000.00 |
| 持续经营筹资活动现金流净额 | $234.62M | $30.64M | $146.00M | $72.40M | $480,000.00 |
| 债务发行及偿还净额 | $0.00 | $24.47M | $73.02M | $0.00 | $0.00 |
| 普通股发行净额 | $234.07M | $6.01M | $72.40M | $72.40M | $0.00 |
| 股票期权行使所得 | $551,000.00 | $170,000.00 | $580,000.00 | $0.00 | $480,000.00 |
| 期末现金余额 | $477.91M | $298.49M | $334.52M | $334.52M | $350.74M |
| 现金净变动 | $179.39M | -$35.54M | $152.98M | -$16.31M | $44.34M |
| 期初现金余额 | $298.49M | $334.52M | $180.43M | $350.74M | $306.68M |
| 汇率变动影响 | $29,000.00 | -$483,000.00 | $1.11M | $91,000.00 | -$285,000.00 |
| 自由现金流 | -$55.56M | -$66.29M | -$196.04M | -$58.79M | -$44.54M |
暂无评论——快来第一个聊聊 MLTX。